Validity and Reliability of Indonesian Translated Ages and Stages Questionnaires – Third Edition (ASQ-3) as a Screening Tool for Developmental Delay in 1-12 Months Old Children
Overview
This study aimed to provide the validity and reliability of the Indonesian ASQ-3 questionnaires as a screening tool for developmentally delayed children aged less than one year old. This study was divided into 2 phases. The first phase (April-June 2018) included the transcultural adaptation of the ASQ-3 questionnaires for 2 to 12 months age groups from English to Indonesian. The second phase (July- September 2018) included a cross-sectional study of Indonesian ASQ-3 questionnaires for parents/caregivers of children aged 1-12 months, with 35 children in each age group by cluster sampling methods, in 2 district areas in East Jakarta.
Full Title of Study: “Validity and Reliability of Indonesian Translated Ages and Stages Questionnaires – Third Edition (ASQ-3) as a Screening Tool for Developmental Delay in 1-12 Months Old Children”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: September 30, 2018
Clinical Trial Outcome Measures
Primary Measures
- Child development
- Time Frame: 1 day (Once)
- Measured once with Indonesian Ages and Stages-3 questionnaire (cross sectional study) with maximum score of 60 per domain.
Participating in This Clinical Trial
Inclusion Criteria
- Parents with children aged 1-12 months – Parents who finished at least elementary school Exclusion Criteria:
- Parents with communication difficulties – Parents who could not speak Indonesian language
Gender Eligibility: All
Minimum Age: 1 Month
Maximum Age: 12 Months
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Indonesia University
- Provider of Information About this Clinical Study
- Principal Investigator: Prof. Hartono Gunardi, MD, PhD, Professor – Indonesia University
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.